Yüklüyor......
Will Hydroxychloroquine Still Be a Game-Changer for COVID-19 by Combining Azithromycin?
Recent small-scale clinical trials have shown promising results in the use of hydroxychloroquine, an FDA approved anti-malaria drug, for the treatment of COVID-19. However, large scale, randomized and double-blind clinical trials are needed to confirm the safety and efficacy of hydroxychloroquine in...
Kaydedildi:
| Yayımlandı: | Front Immunol |
|---|---|
| Asıl Yazarlar: | , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Frontiers Media S.A.
2020
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7426511/ https://ncbi.nlm.nih.gov/pubmed/32849658 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fimmu.2020.01969 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|